Back to top
more

Johnson & Johnson (JNJ)

(Delayed Data from NYSE)

$144.77 USD

144.77
9,377,510

+0.32 (0.22%)

Updated Apr 17, 2024 04:00 PM ET

After-Market: $144.78 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy18.00%
3Hold9.44%
4Sell5.10%
5Strong Sell2.53%
S&P50011.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 22% (195 out of 251)

Industry: Large Cap Pharmaceuticals

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for JNJ

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Johnson & Johnson falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 22,927 23,519 31,608 25,185 19,287
Receivables 14,873 16,160 15,283 13,576 14,481
Notes Receivable 0 0 0 0 0
Inventories 11,181 12,483 10,387 9,344 9,020
Other Current Assets 4,514 3,132 3,701 3,132 2,486
Total Current Assets 53,495 55,294 60,979 51,237 45,274
Net Property & Equipment 19,898 19,803 18,962 18,766 17,658
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 9,279 9,123 10,223 8,534 7,819
Intangibles 70,733 93,556 81,638 89,795 81,282
Deposits & Other Assets 14,153 9,602 10,216 6,562 5,695
Total Assets 167,558 187,378 182,018 174,894 157,728
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 3,451 12,771 3,766 2,631 1,202
Accounts Payable 9,632 11,703 11,055 9,505 8,544
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 30,206 29,201 29,293 28,965 23,952
Income Taxes Payable 2,993 2,127 1,112 1,392 2,266
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 46,282 55,802 45,226 42,493 35,964
Mortgages 0 0 0 0 0
Deferred Taxes/Income 3,193 6,374 7,487 7,214 5,958
Convertible Debt 0 0 0 0 0
Long-Term Debt 25,881 26,888 29,985 32,635 26,494
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 23,428 21,510 25,297 29,274 29,841
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 98,784 110,574 107,995 111,616 98,257
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 3,120 3,120 3,120 3,120 3,120
Capital Surplus 0 0 0 0 0
Retained Earnings 153,843 128,345 123,060 113,890 110,659
Other Equity -12,527 -12,967 -13,058 -15,242 -15,891
Treasury Stock 75,662 41,694 39,099 38,490 38,417
Total Shareholder's Equity 68,774 76,804 74,023 63,278 59,471
Total Liabilities & Shareholder's Equity 167,558 187,378 182,018 174,894 157,728
Total Common Equity 68,774 76,804 74,023 63,278 59,471
Shares Outstanding 2,407.20 2,613.60 2,632.60 2,632.50 2,631.80
Book Value Per Share 28.57 29.39 28.12 24.04 22.60

Fiscal Year End for Johnson & Johnson falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 22,927 23,511 28,505 32,308
Receivables NA 14,873 14,798 16,777 16,350
Notes Receivable NA 0 0 0 0
Inventories NA 11,181 11,198 12,888 12,809
Other Current Assets NA 4,514 4,196 2,397 2,921
Total Current Assets NA 53,495 53,703 60,567 64,388
Net Property & Equipment NA 19,898 18,821 20,576 20,174
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 9,279 9,259 8,779 8,817
Intangibles NA 70,733 71,145 91,686 93,023
Deposits & Other Assets NA 14,153 13,133 10,078 9,567
Total Assets NA 167,558 166,061 191,686 195,969
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 3,451 3,870 11,701 17,979
Accounts Payable NA 9,632 8,355 10,443 9,909
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 30,206 29,246 29,339 28,219
Income Taxes Payable NA 2,993 2,899 2,687 4,266
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 46,282 44,370 54,170 60,373
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 3,193 2,623 3,627 4,417
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 25,881 26,051 33,901 34,928
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 21,789 23,579 25,382
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 98,784 94,833 115,277 125,100
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 3,120 3,120 3,120 3,120
Capital Surplus NA 0 0 0 0
Retained Earnings NA 153,843 152,536 129,381 124,558
Other Equity NA -12,527 -8,780 -11,875 -12,626
Treasury Stock NA 75,662 75,648 44,217 44,183
Total Shareholder's Equity NA 68,774 71,228 76,409 70,869
Total Liabilities & Shareholder's Equity NA 167,558 166,061 191,686 195,969
Total Common Equity 0 68,774 71,228 76,409 70,869
Shares Outstanding 2,409.70 2,407.20 2,407.20 2,598.90 2,598.70
Book Value Per Share 0.00 28.57 29.59 29.40 27.27